Your browser doesn't support javascript.
loading
An mRNA assay system demonstrates proteasomal-specific degradation contributes to cardiomyopathic phospholamban null mutation.
Rohner, Eduarde; Witman, Nevin; Sohlmer, Jesper; De Genst, Erwin; Louch, William E; Sahara, Makoto; Chien, Kenneth R.
Afiliação
  • Rohner E; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
  • Witman N; Integrated Cardio Metabolic Center, Department of Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Sohlmer J; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
  • De Genst E; Integrated Cardio Metabolic Center, Department of Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Louch WE; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Sahara M; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
  • Chien KR; Integrated Cardio Metabolic Center, Department of Medicine, Karolinska Institutet, Huddinge, Sweden.
Mol Med ; 27(1): 102, 2021 09 08.
Article em En | MEDLINE | ID: mdl-34496741

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Ligação ao Cálcio / RNA Mensageiro / Complexo de Endopeptidases do Proteassoma / Homozigoto / Mutação / Cardiomiopatias Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Ligação ao Cálcio / RNA Mensageiro / Complexo de Endopeptidases do Proteassoma / Homozigoto / Mutação / Cardiomiopatias Idioma: En Ano de publicação: 2021 Tipo de documento: Article